Atossa Therapeutics Presents Clinical Trial Update Highlighting (Z)-Endoxifen Research at the 2026 MDA Clinical & Scientific Conference
NASDAQ:ATOS|Neutral|12 Mar 2026 · 1 day ago
Read More →Want to know each day's companies with the most bullish news?
1 article · filtered by ATOS